@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/spar/datacite/> .
@prefix ns3: <http://purl.org/vocab/frbr/core#> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/061901561817> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 061901561817" ;
    ns4:publicationDate "2018-09-26"^^xsd:date ;
    dcterms:title "Atypical Pharmacodynamic Properties And Metabolic Profile Of The Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution To Pronounced Adverse Effects Relative To Î9-THC" ;
    ns2:hasIdentifier <https://w3id.org/oc/meta/id/061104383803>,
        <https://w3id.org/oc/meta/id/061901589868>,
        <https://w3id.org/oc/meta/id/06706071671> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/061906830977>,
        <https://w3id.org/oc/meta/ar/061906830978>,
        <https://w3id.org/oc/meta/ar/061906830979>,
        <https://w3id.org/oc/meta/ar/061906830980>,
        <https://w3id.org/oc/meta/ar/061906830981>,
        <https://w3id.org/oc/meta/ar/061906830982>,
        <https://w3id.org/oc/meta/ar/061906830983>,
        <https://w3id.org/oc/meta/ar/061906830984>,
        <https://w3id.org/oc/meta/ar/061906830985>,
        <https://w3id.org/oc/meta/ar/061906830986>,
        <https://w3id.org/oc/meta/ar/061906830987>,
        <https://w3id.org/oc/meta/ar/061906830988>,
        <https://w3id.org/oc/meta/ar/061906830989>,
        <https://w3id.org/oc/meta/ar/061906830990>,
        <https://w3id.org/oc/meta/ar/061906830991> ;
    ns3:embodiment <https://w3id.org/oc/meta/re/06010045410> ;
    ns3:partOf <https://w3id.org/oc/meta/br/0618035370> .

